Pasar al contenido principal

Metallodrug as theranostic agents

RYC2018-025872-I

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Incorporación
Convocatoria Ramón y Cajal
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE ZARAGOZA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 19
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Luminescent bimetallic IrIII/AuI peptide bioconjugates as potential theranostic agents

  • Luengo, Andrés
  • Marzo, Isabel
  • Reback, Matthew
  • Daubit, Isabelle M.
  • Fernández-Moreira, Vanesa
  • Metzler-Nolte, Nils
  • Gimeno, M. Concepción
Diverse iridium peptide bioconjugates and the corresponding iridium/gold bimetallic complexes have been synthesized starting from a cyclometallated carboxylic acid substituted IrIII complex [Ir(ppy)2(Phen‐5‐COO)] by solid phase peptide synthesis (SPPS). The selected peptide sequences were an enkephalin derivative Tyr‐Gly‐Gly‐Phe‐Leu together with the propargyl‐substituted species Tyr‐Gly‐Pgl‐Phe‐Leu to allow gold coordination (Pgl: propyrgyl‐glycine, HC≡C‐Gly), and a specific short peptide, Ala‐Cys‐Ala‐Phen, containing a cysteine residue. Introduction of the gold center has been achieved via a click reaction with the alkynyl group leading to an organometallic Au−C(triazole) species, or by direct coordination to the sulfur atom of the cysteine. The photophysical properties of these species revealed predominantly an emission originating from the Ir complex, using mixed metal‐to‐ligand and ligand‐to‐ligand charge transfer excited states of triplet multiplicity. The formation of the peptide bioconjugates caused a systematic redshift of the emission profiles. Lysosomal accumulation was observed for all the complexes, in contrast to the expected mitochondrial accumulation triggered by the gold complexes. Only the cysteine‐containing Ir/Au bioconjugate displayed cytotoxic activity. The absence of activity may be related to the lack of endosomal/lysosomal escape for the cationic peptide conjugates. Interestingly, the different coordination sphere of the gold atom may play a crucial role, as the Au−S(cysteine) bond may be more readily cleaved in a biological environment than the Au−C(triazole) bond, and thus the Au fragment could be released from or trapped in the lysosomes, respectively. This work represents a starting point in the development of bimetallic peptide bioconjugates as theranostics and in the knowledge of factors that contribute to anti‐proliferative activity., Authors thank the Ministerio de Ciencia Innovación (projects CTQ2016‐75816‐C2‐1‐P, PID2019‐104379RB‐C21, RTI2018‐097836‐J‐I00, RYC2018‐025872‐I and RED2018‐102471‐T) and Gobierno de Aragón‐Fondo Social Europeo (E07 20R) for financial support. A. L. thanks the Gobierno de Aragón for a predoctoral fellowship as well as Universidad de Zaragoza, Fundación Bancaria Ibercaja and Fundación Cai for a doctoral stay fellowship (CB 7/17)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Novel ureido-dihydropyridine scaffolds as theranostic agents

  • Auria-Luna, Fernando
  • Marqués-López, Eugenia
  • Romanos, Eduardo
  • Fernández-Moreira, Vanesa
  • Gimeno, M. Concepción
  • Marzo, Isabel
  • Herrera, Raquel P.
In this work, the synthesis of interesting urea derivatives 5 based on 1,4-dihydropyridines 3 is described for the first time. Considering that both families exhibit potential as drugs to treat various diseases, their activity as anticancer agents has been evaluated in HeLa (cervix), Jurkat (leukaemia) and A549 (lung) cancer cell lines as well as on healthy mice in vivo. In general, whereas 1,4-dihydropyridines show a moderate cytotoxic activity, their urea analogues cause an extraordinary increase in their antiproliferative activity, specially towards HeLa cells. Because of the chiral nature of these compounds, enantiomerically enriched samples were also tested, showing different cytotoxic activity than the racemic mixture. Although the reason is not clear, it could be caused by a complex amalgam of physical and chemical contributions. The studied compounds also exhibit luminescent properties, which allow performing a biodistribution study in cancer cells. They have emission maxima between 420 and 471 nm, being the urea derivatives in general red shifted. Emission quenching was observed for those compounds containing a nitro group (3e,f and 5e,f). Fluorescence microscopy showed that 1,4-dihydropyridines 3a and 3g localised in the lysosomes, in contrast to the urea derivatives 5h that accumulated in the cell membrane. This different distribution could be key to explain the differences found in the cytotoxic activity and in the mechanism of action. Interestingly, a preliminary in vivo study regarding the acute toxicity of some of these compounds on healthy mice has been conducted, using a concentration up to 7200 times higher than the corresponding IC50 value. No downgrade in the welfare of the tested mice was observed, which could support their use in preclinical tumour models., This work was supported by a 2018 Leonardo Grant for Researchers and Cultural Creators, BBVA Foundation, Ministerio de Economía, Industria y Competitividad (MINECO-FEDER CTQ2016-75816-C2-1-P, CTQ2017-88091-P, PID2019-104379RB-C21, RTI2018-097836-J-I00, RYC2018-025872-I and RED2018-102471-T) and Gobierno de Aragón-Fondo Social Europeo (Research Group E07_20R)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Ultrasound-assisted multicomponent synthesis of 4H-pyrans in water and DNA binding studies

  • Auria-Luna, Fernando
  • Fernández-Moreira, Vanesa
  • Marqués-López, Eugenia
  • Gimeno, M. Concepción
  • Herrera, Raquel P.
A simple approach to synthesize new highly substituted 4H-pyran derivatives is described. Efficient Et3N acts as a readily accessible catalyst of this process performed in pure water and with only a 20 mol% of catalyst loading. The extremely simple operational methodology, short reaction times, clean procedure and excellent product yields render this new approach extremely appealing for the synthesis of 4H-pyrans, as potentially biological scaffolds. Additionally, DNA interaction analysis reveals that 4H-pyran derivatives behave preferably as minor groove binders over major groove or intercalators. Therefore, this is one of the scarce examples where pyrans have resulted to be interesting DNA binders with high binding constants (Kb ranges from 1.53 × 104 M−1 to 2.05 × 106 M−1)., This work was supported by a 2018 Leonardo Grant for Researchers and Cultural Creators, BBVA Foundation. The authors also thank Ministerio de Economía, Industria y Competitividad (MINECO-FEDER CTQ2016-75816-C2-1-P, CTQ2017-88091-P, PID2019-104379RB-C21, RTI2018-097836-J-I00, RED2018-102471-T and RYC2018-025872-I) and Gobierno de Aragón-Fondo Social Europeo (Research Group E07_20R) for financial support of our research., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Theranostics through the synergistic cooperation of heterometallic complexes

  • Redrado, Marta
  • Fernández-Moreira, Vanesa
  • Gimeno, M. Concepción
Heterometallic drugs are emerging as a great alternative to conventional metallodrugs. Careful selection of different metallic fragments makes possible to enhance not only the therapeutic potential by a synergistic effect, but also to incorpore key features like traceability. Drugs that integrate traceability and therapy in one system are known as theranostic agents. In cancer research, theranostic agents are becoming increasingly important. They deliver crucial information regarding their biological interplay that can ultimately be used for optimization. The well‐established therapeutic potential of PtII‐, RuII‐ and AuI‐based drugs combined with the outstanding optical properties of d6 transition metal complexes grant the delivery of traceable metallodrugs. These species can be easily fine‐tuned through modification of their respective ligands to provide a new generation of drugs., The authors thank the AEI (Ministerio de Ciencia Innovación y Universidades) for projects PID2019‐104379RB−C21, RTI2018‐097836‐J−I00, RYC2018‐025872 and RED2018‐102471‐T, and Gobierno de Aragón‐Fondo Social Europeo (E07_20R) for financial support. M.R. thanks the Gobierno de Aragón for a predoctoral fellowship., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Dual emissive Ir(III) complexes for photodynamic therapy and bioimaging

  • Redrado, Marta
  • Benedi, Andrea
  • Marzo, Isabel
  • Gimeno, M. Concepción
  • Fernández-Moreira, Vanesa
This article belongs to the Special Issue Metallodrugs for Targeted Cancer Therapy., Photodynamic therapy (PDT) is a cancer treatment still bearing enormous prospects of improvement. Within the toolbox of PDT, developing photosensitizers (PSs) that can specifically reach tumor cells and promote the generation of high concentration of reactive oxygen species (ROS) is a constant research goal. Mitochondria is known as a highly appealing target for PSs, thus being able to assess the biodistribution of the PSs prior to its light activation would be crucial for therapeutic maximization. Bifunctional Ir(III) complexes of the type [Ir(C^N)2(N^N-R)]+, where N^C is either phenylpyridine (ppy) or benzoquinoline (bzq), N^N is 2,2′-dipyridylamine (dpa) and R either anthracene (1 and 3) or acridine (2 and 4), have been developed as novel trackable PSs agents. Activation of the tracking or therapeutic function could be achieved specifically by irradiating the complex with a different light wavelength (405 nm vs. 470 nm respectively). Only complex 4 ([Ir(bzq)2(dpa-acr)]+) clearly showed dual emissive pattern, acridine based emission between 407–450 nm vs. Ir(III) based emission between 521 and 547 nm. The sensitivity of A549 lung cancer cells to 4 evidenced the importance of involving the metal center within the activation process of the PS, reaching values of photosensitivity over 110 times higher than in dark conditions. Moreover, complex 4 promoted apoptotic cell death and possibly the paraptotic pathway, as well as higher ROS generation under irradiation than in dark conditions. Complexes 2–4 accumulated in the mitochondria but species 2 and 4 also localizes in other subcellular organelles., This research was funded by the Agencia Estatal de Investigación (projects PID2019-104379RB-C21, RTI2018-097836-J-I00, RYC2018-025872-I and RED2018-102471-T), and Gobierno de Aragón-Fondo Social Europeo (E07_20R)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Luminescent gold–thallium derivatives with a pyridine-containing 12-membered aza-thioether macrocycle

  • Caddeo, Francesco
  • Fernández-Moreira, Vanesa
  • Arca, Massimiliano
  • Pintus, Anna
  • Laguna, Antonio
  • Lippolis, Vito
  • Gimeno, M. Concepción
The coordination modes of the ligand 2,5,8-trithia[9](2,6)pyridinophane (L) to thallium(I), gold(III) and gold(I) have been studied. Thallium(I) is coordinated by the macrocyclic ligand in [Tl(L)](PF6) (1) through all the sulfur and nitrogen atoms, in a distorted square-pyramidal geometry with the thallium(I) ion in the apical position and with the presence of an inert lone pair. Gold(III) is bonded by the ligand only through the nitrogen of the pyridine group in [AuCl3(L)] (2), whereas two AuI–C6F5 fragments coordinate the sulfur atoms next to the pyridine moiety of the ligand in [{Au(C6F5)}2(μ-L)] (3), which form a linear polymer through intermolecular aurophilic contacts. The heterometallic TlI/AuI complex {[Au(C6F5)2Tl]2(L)}n (4) features a polymeric structural nature with a metallic pseudo-rhombic Au2Tl2 core, which repeats itself forming a zig-zag polymer. In each Au2Tl2 unit only one thallium atom is bonded by the NS3 donor set of the macrocyclic ligand and also forms two unsupported Au–Tl bonds with two [Au(C6F5)2]− units in an overall pseudo-octahedral geometry. The other thallium atom similarly bridges the same [Au(C6F5)2]− units and links a neighbouring Au2Tl2 moiety, thus exhibiting a distorted trigonal planar geometry being bonded only to three gold atoms with unsupported Au–Tl interactions. This complex displays an interesting thermochromic behaviour showing emissions mainly resulting from MM′CT transitions at room temperature. At 77 K a dual emission appears, probably arising from the two different thallium environments. DFT calculations have been carried out in the attempt to investigate the origin of the emissions of complex 4., Authors thank the Agencia Estatal de Investigación (projects PID2019-104379RB-C21, RTI2018-097836-J100 and RYC2018-025872), Gobierno de Aragón–Fondo Social Europeo (Research Group E07_20R) and the Fondazione di Sardegna (FdS) and Regione Autonoma della Sardegna (RAS) (Progetti Biennali di Ateneo FdS/RAS annualità 2018) for financial support of our research. A. P. acknowledges RAS for the funding in the context of the POR FSE 2014–2020 (CUP F24J17000190009)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Multifunctional heterometallic IrIII−AuI probes as promising anticancer and antiangiogenic agents

  • Redrado, Marta
  • Benedi, Andrea
  • Marzo, Isabel
  • García-Otín, Angel L.
  • Fernández-Moreira, Vanesa
  • Gimeno, M. Concepción
A new class of emissive cyclometallated IrIII−AuI complexes with a bis(diphenylphosphino) methanide bridging ligand was successfully synthesised from the diphosphino complex [Ir(N^C)2(dppm)]+ (1). The different gold ancillary ligand, a triphenylphosphine (2), a chloride (3) or a thiocytosine (4) did not reveal any significant effect on the photophysical properties, which are mainly due to metal-to-ligand charge-transfer (3MLCT) transitions based on IrIII. However, the AuI fragment, along with the ancillary ligand, seemed crucial for the bioactivity in A549 lung carcinoma cells versus endothelial cells. Both cell types display variable sensitivities to the complexes (IC50=0.6–3.5 μM). The apoptotic pathway is activated in all cases, and paraptotic cell death seems to take place at initial stages in A549 cells. Species 2–4 showed at least dual lysosomal and mitochondrial biodistribution in A549 cells, with an initial lysosomal localisation and a possible trafficking process between both organelles with time. The bimetallic IrIII−AuI complexes disrupted the mitochondrial transmembrane potential in A549 cells and increased reactive oxygen species (ROS) generation and thioredoxin reductase (TrxR) inhibition in comparison with that displayed by the monometallic complex 1. Angiogenic activity assays performed in endothelial cells revealed the promising antimetastatic potential of 1, 2 and 4., Authors thank the Agencia Estatal de Investigación (projects PID2019-104379RB−C21, RTI2018-097836-J−I00, RYC2018-025872-I and RED2018-102471-T), Instituto de Salud Carlos III (PI16/02112), and Gobierno de Aragón-Fondo Social Europeo (E07_20R, B04_20R) for financial support. M.R.D thanks the Gobierno de Aragón for a predoctoral fellowship., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synthesis and antiproliferative study of phosphorescent multimetallic Re(I)/Au(I) complexes containing fused imidazo[4,5-f]-1,10-phenanthroline core

  • Luengo, Andrés
  • Marzo, Isabel
  • Fernández-Moreira, Vanesa
  • Gimeno, M. Concepción
Five heterobimetallic ReI/AuI and a tri-metallic ReI/AuI/ReI species following the formulas fac-[ReCl (CO)3(N^N^CAuR)]0/+ and [(fac-[ReCl (CO)3(N^N^C)])2Au]+, where R is an iodide (1), phenylacetylene (2), dodecanethiol (3), 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranose (4) and JohnPhos (5) and N^N^C is the fused imidazo[4,5-f]-1,10-phenanthroline heterotopic ligand, were synthesised and fully characterised by a variety of spectroscopic and analytical techniques. The resultant complexes are luminescent in the orange region, revealing classical metal-to-ligand charge transfer (3MLCT) ((Re (dπ) → (N^N^C)(π*)) emission in aerated DMSO solution. The red shifted emission observed on going from 3 to 4 suggests that the electronic properties of the gold ancillary ligand are implicated in the emissive properties. Antiproliferative activity in tumour cell lines, lung (A549) and cervix (HeLa) cells revealed that only complex 4 containing a 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranose as gold ancillary ligand possesses certain cytotoxicity in both cell lines., Authors thank the Agencia Estatal de Investigación, projects PID2019-104379RB-C21/AEI /10.13039/501100011033, RTI2018-097836-J-I00/MCIN/AEI/10.13039/501100011033/FEDER, RYC2018-025872-I (funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”), RED2018-102471-T/MCIN/AEI/10.13039/501100011033, and Gobierno de Aragón-Fondo Social Europeo (E07_20R) for financial support. A.L. thanks the Gobierno de Aragón for a predoctoral fellowship., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Tunable emissive Ir(III) benzimidazole-quinoline hybrids as promising theranostic lead compounds

  • Redrado, Marta
  • Miñana, Miriam
  • Coogan, Michael P.
  • Gimeno, M. Concepción
Bioactive and luminescent cyclometallated Ir(III) complexes [Ir(ppy)2L1]Cl (1) and [Ir(ppy)2L2]Cl (2) containing a benzimidazole derivative (L1/L2) as auxiliary mimic of a nucleotide have been synthesised. The emissive properties of both complexes are conditioned by the nature of L1 and L2, rendering an orange and a green emitter respectively. Both are highly emissive with quantum yield increasing in absence of oxygen up to 0.26 (1) and 0.36 (2), suggesting their phosphorescent character. Antiproliferative activity against lung cancer A549 cells increased up to 15 times upon irradiation conditions, reaching IC50 values in the nanomolar range (0.3±0.09 μM (1) and 0.26±0.14 μM (2)) and pointing them as good PSs candidates for photodynamic therapy via 1O2 generation. Cellular biodistribution analysis by fluorescence microscopy suggest the lysosomes as the preferential accumulation organelle. Time-resolved studies showed a greatly increased cellular emission lifetime compared to the solution values, indicating binding to macromolecules or cellular structures and restriction of collision and vibrational quenching., Authors thank the Agencia Estatal de Investigación, projects PID2019-104379RB-C21/AEI/10.13039/501100011033, RTI2018-097836-J-I00/MCIN/AEI/10.13039/501100011033/FEDER, RYC2018-025872-I (funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”), RED2018-102471-T/MCIN/AEI/10.13039/501100011033, and Gobierno de Aragón-Fondo Social Europeo (E07_20R) for financial support. M. R. thanks the Gobierno de Aragón for a predoctoral fellowship., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

1-Benzamido-1,4-dihydropyridine derivatives as anticancer agents: in vitro and in vivo assays

  • Ardevines, Sandra
  • Auria-Luna, Fernando
  • Romanos, Eduardo
  • Fernández-Moreira, Vanesa
  • Benedi, Andrea
  • Gimeno, M. Concepción
  • Marzo, Isabel
  • Marqués-López, Eugenia
  • Herrera, Raquel P.
1,4-Dihydropyridine is a privileged scaffold present in many bioactive molecules, from coenzymes to commercially available drugs. Among other interesting properties, it has been found good anticancer activity in some of these 1,4-DHPs, therefore many research groups are trying to develop new compounds based on this structural core. For this purpose, in this work, a family of 23 new 1,4-dihydropyridines has been synthesized using hydrazide and malononitrile derivatives as precursors. This straightforward catalytic process has given rise to the desired products with moderate to excellent yields. All the compounds have been tested against four different cancer cell lines [HeLa (human cervical carcinoma), Jurkat (leukemia), A549 (human lung cancer) and MIA PaCa-2 (pancreatic cancer)] to establish a preliminary structure–activity relationship. From this study, and among the best candidates, we chose 4-chlorophenyl and 4-(trifluoromethyl)phenyl derivatives in the malononitrile ring to synthesize a second generation of molecules with enhanced cytotoxicity, modifying the substituent in the N-heterocyclic position (acylhydrazine moieties). With this second generation of compounds, we successfully decreased the IC50 until 7 µM. An in-depth analysis of their biological properties suggests that these promising compounds trigger a non-conventional cell death mechanism known as paraptosis. Moreover, the tested photophysical properties of these products show in some cases an interesting long wavelength emission and excitation, potentially leading to new biosensors or theragnostic agents. Finally, in vivo assays concerning the acute toxicity in mice of two of the most active compounds (with an alkyl chain of seven carbon atoms in the acylhydrazine moiety) demonstrated that even dosed at thousands fold the corresponding IC50 values (2500 and 3300 times more concentrated than the IC50 values for the two compounds studied), there was no sign of harmful effects on the tested subjects, results that support their use in further studies to discover new anticancer drugs., The authors thank Agencia Estatal de Investigación (AEI), project PID2019-104379RB-C21 and PID2020-117455GB-I00/AEI/10.13039/501100011033; RED2018-102471-T (MCIN/AEI/10.13039/501100011033), RTI2018-097836-J-I00 (MCIN/AEI/10.13039/501100011033/FEDER), RYC2018-025872-I (MCIN/AEI/10.13039/501100011033), by “ESF Investing in your future” and Gobierno de Aragón-Fondo Social Europeo (Research Groups E07_20R and B31_20R) for financial support of this research. S. A. thanks the DGA (Aragon Government) for a predoctoral fellowship., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The role of metallodrugs in cellular senescence

  • Redrado, Marta
  • Fernández-Moreira, Vanesa
Delivering alternative strategies to deal with cancer is a huge milestone in research. Cancer cells can give a senescence response as consequence of cellular stress or external stimuli such as the use of chemotherapies, which could end up eventually in cancer relapse. Controlling cellular senescence will surely open new cancer treatment approaches. Cancer senescence induction can be used as an added timeframe to look for alternative treatments and senolytic drugs to avoid cancer relapse destroying the senescent cells (SnCs). Within cancer senescence research, metal complexes are underdeveloped in comparison with that of organic molecules or nanoparticles. Herein, we highlight the scarce investigation performed with metal complexes in the field of senescence and how a great input on them could be a huge step towards the search of alternative cancer treatments., Authors thank the Agencia Estatal de Investigación, RTI2018-097836-J−I00 / MCIN / AEI /10.13039/501100011033/ FEDER, RYC2018-025872-I (funded by MCIN/AEI/ 10.13039/501100011033 and by “ESF Investing in your future”), RED2018-102471-T / MCIN/AEI /10.13039/501100011033, and Gobierno de Aragón-Fondo Social Europeo (E07_20R) for financial support. M.R. thanks the Gobierno de Aragón for a predoctoral fellowship. M.R. thanks Dr. D. Muñoz-Espín for the training and transfer of knowledge in cancer SnCs., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synthesis and antiproliferative study of phosphorescent multimetallic Re(I)/Au(I) complexes containing fused imidazo[4,5-f]-1,10-phenanthroline core

  • Luengo, Andrés
  • Marzo, Isabel
  • Fernández-Moreira, Vanesa
  • Gimeno, M. Concepción
Five heterobimetallic ReI/AuI and a tri-metallic ReI/AuI/ReI species following the formulas fac-[ReCl (CO)3(N^N^CAuR)]0/+ and [(fac-[ReCl (CO)3(N^N^C)])2Au]+, where R is an iodide (1), phenylacetylene (2), dodecanethiol (3), 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranose (4) and JohnPhos (5) and N^N^C is the fused imidazo[4,5-f]-1,10-phenanthroline heterotopic ligand, were synthesised and fully characterised by a variety of spectroscopic and analytical techniques. The resultant complexes are luminescent in the orange region, revealing classical metal-to-ligand charge transfer (3MLCT) ((Re (dπ) → (N^N^C)(π*)) emission in aerated DMSO solution. The red shifted emission observed on going from 3 to 4 suggests that the electronic properties of the gold ancillary ligand are implicated in the emissive properties. Antiproliferative activity in tumour cell lines, lung (A549) and cervix (HeLa) cells revealed that only complex 4 containing a 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranose as gold ancillary ligand possesses certain cytotoxicity in both cell lines., Authors thank the Agencia Estatal de Investigación, projects PID2019-104379RB-C21/AEI /10.13039/501100011033, RTI2018-097836-J-I00/MCIN/AEI/10.13039/501100011033/FEDER, RYC2018-025872-I (funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”), RED2018-102471-T/MCIN/AEI/10.13039/501100011033, and Gobierno de Aragón-Fondo Social Europeo (E07_20R) for financial support. A.L. thanks the Gobierno de Aragón for a predoctoral fellowship., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Ultrasound-assisted multicomponent synthesis of 4H-pyrans in water and DNA binding studies

  • Auria-Luna, Fernando
  • Fernández-Moreira, Vanesa
  • Marqués-López, Eugenia
  • Gimeno, M. Concepción
  • Pérez Herrera, Raquel
A simple approach to synthesize new highly substituted 4H-pyran derivatives is described. Efficient Et3N acts as a readily accessible catalyst of this process performed in pure water and with only a 20 mol% of catalyst loading. The extremely simple operational methodology, short reaction times, clean procedure and excellent product yields render this new approach extremely appealing for the synthesis of 4H-pyrans, as potentially biological scaffolds. Additionally, DNA interaction analysis reveals that 4H-pyran derivatives behave preferably as minor groove binders over major groove or intercalators. Therefore, this is one of the scarce examples where pyrans have resulted to be interesting DNA binders with high binding constants (Kb ranges from 1.53 × 104 M-1 to 2.05 × 106 M-1).
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Luminescent Bimetallic IrIII /AuI Peptide Bioconjugates as Potential Theranostic Agents

  • Luengo, A.
  • Marzo, I.
  • Reback, M.
  • Daubit, I.M.
  • Fernández-Moreira, V.
  • Metzler-Nolte, N.
  • Gimeno, M.C.
Diverse iridium peptide bioconjugates and the corresponding iridium/gold bimetallic complexes have been synthesized starting from a cyclometallated carboxylic acid substituted IrIII complex [Ir(ppy)2 (Phen-5-COO)] by solid phase peptide synthesis (SPPS). The selected peptide sequences were an enkephalin derivative Tyr-Gly-Gly-Phe-Leu together with the propargyl-substituted species Tyr-Gly-Pgl-Phe-Leu to allow gold coordination (Pgl: propyrgyl-glycine, HC=C-Gly), and a specific short peptide, Ala-Cys-Ala-Phen, containing a cysteine residue. Introduction of the gold center has been achieved via a click reaction with the alkynyl group leading to an organometallic Au-C(triazole) species, or by direct coordination to the sulfur atom of the cysteine. The photophysical properties of these species revealed predominantly an emission originating from the Ir complex, using mixed metal-to-ligand and ligand-to-ligand charge transfer excited states of triplet multiplicity. The formation of the peptide bioconjugates caused a systematic redshift of the emission profiles. Lysosomal accumulation was observed for all the complexes, in contrast to the expected mitochondrial accumulation triggered by the gold complexes. Only the cysteine-containing Ir/Au bioconjugate displayed cytotoxic activity. The absence of activity may be related to the lack of endosomal/lysosomal escape for the cationic peptide conjugates. Interestingly, the different coordination sphere of the gold atom may play a crucial role, as the Au-S(cysteine) bond may be more readily cleaved in a biological environment than the Au-C(triazole) bond, and thus the Au fragment could be released from or trapped in the lysosomes, respectively. This work represents a starting point in the development of bimetallic peptide bioconjugates as theranostics and in the knowledge of factors that contribute to anti-proliferative activity.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Multifunctional heterometallic Iriii-Aui probes as promising anticancer and antiangiogenic agents

  • Redrado M.
  • Benedi A.
  • Marzo I.
  • García-Otín A.L.
  • Fernández-Moreira V.
  • Gimeno M. Concepción
A new class of emissive cyclometallated IrIII-AuI complexes with a bis(diphenylphosphino) methanide bridging ligand was successfully synthesised from the diphosphino complex [Ir(N^C)2(dppm)]+ (1). The different gold ancillary ligand, a triphenylphosphine (2), a chloride (3) or a thiocytosine (4) did not reveal any significant effect on the photophysical properties, which are mainly due to metal-to-ligand charge-transfer (3MLCT) transitions based on IrIII. However, the AuI fragment, along with the ancillary ligand, seemed crucial for the bioactivity in A549 lung carcinoma cells versus endothelial cells. Both cell types display variable sensitivities to the complexes (IC50=0.6–3.5 µM). The apoptotic pathway is activated in all cases, and paraptotic cell death seems to take place at initial stages in A549 cells. Species 2–4 showed at least dual lysosomal and mitochondrial biodistribution in A549 cells, with an initial lysosomal localisation and a possible trafficking process between both organelles with time. The bimetallic IrIII-AuI complexes disrupted the mitochondrial transmembrane potential in A549 cells and increased reactive oxygen species (ROS) generation and thioredoxin reductase (TrxR) inhibition in comparison with that displayed by the monometallic complex 1. Angiogenic activity assays performed in endothelial cells revealed the promising antimetastatic potential of 1, 2 and 4. © 2021 The Authors. Chemistry - A European Journal published by Wiley-VCH GmbH.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Tunable Emissive Ir(III) Benzimidazole-quinoline Hybrids as Promising Theranostic Lead Compounds

  • Redrado, Marta
  • Miñana, Miriam
  • Coogan, Michael P.
  • Gimeno, M. Concepción
  • Fernández Moreira, Vanesa
Bioactive and luminescent cyclometallated Ir(III) complexes Ir(ppy)2L1]Cl (1) and Ir(ppy)2L2]Cl (2) containing a benzimidazole derivative (L1/L2) as auxiliary mimic of a nucleotide have been synthesised. The emissive properties of both complexes are conditioned by the nature of L1 and L2, rendering an orange and a green emitter respectively. Both are highly emissive with quantum yield increasing in absence of oxygen up to 0.26 (1) and 0.36 (2), suggesting their phosphorescent character. Antiproliferative activity against lung cancer A549 cells increased up to 15 times upon irradiation conditions, reaching IC50 values in the nanomolar range (0.3±0.09 µM (1) and 0.26±0.14 µM (2)) and pointing them as good PSs candidates for photodynamic therapy via 1O2 generation. Cellular biodistribution analysis by fluorescence microscopy suggest the lysosomes as the preferential accumulation organelle. Time-resolved studies showed a greatly increased cellular emission lifetime compared to the solution values, indicating binding to macromolecules or cellular structures and restriction of collision and vibrational quenching.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

The role of metallodrugs in cellular senescence

  • Redrado, Marta
  • Fernández-Moreira, Vanesa
Delivering alternative strategies to deal with cancer is a huge milestone in research. Cancer cells can give a senescence response as consequence of cellular stress or external stimuli such as the use of chemotherapies, which could end up eventually in cancer relapse. Controlling cellular senescence will surely open new cancer treatment approaches. Cancer senescence induction can be used as an added timeframe to look for alternative treatments and senolytic drugs to avoid cancer relapse destroying the senescent cells (SnCs). Within cancer senescence research, metal complexes are underdeveloped in comparison with that of organic molecules or nanoparticles. Herein, we highlight the scarce investigation performed with metal complexes in the field of senescence and how a great input on them could be a huge step towards the search of alternative cancer treatments.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

1-Benzamido-1,4-dihydropyridine derivatives as anticancer agents: in vitro and in vivo assays

  • Ardevines, Sandra
  • Auria-Luna, Fernando
  • Romanos, Eduardo
  • Fernández-Moreira, Vanesa
  • Benedi, Andrea
  • Gimeno, M. Concepción
  • Marzo, Isabel
  • Marqués-López, Eugenia
  • Herrera, Raquel P.
1,4-Dihydropyridine is a privileged scaffold present in many bioactive molecules, from coenzymes to commercially available drugs. Among other interesting properties, it has been found good anticancer activity in some of these 1,4-DHPs, therefore many research groups are trying to develop new compounds based on this structural core. For this purpose, in this work, a family of 23 new 1,4-dihydropyridines has been synthesized using hydrazide and malononitrile derivatives as precursors. This straightforward catalytic process has given rise to the desired products with moderate to excellent yields. All the compounds have been tested against four different cancer cell lines [HeLa (human cervical carcinoma), Jurkat (leukemia), A549 (human lung cancer) and MIA PaCa-2 (pancreatic cancer)] to establish a preliminary structure–activity relationship. From this study, and among the best candidates, we chose 4-chlorophenyl and 4-(trifluoromethyl)phenyl derivatives in the malononitrile ring to synthesize a second generation of molecules with enhanced cytotoxicity, modifying the substituent in the N-heterocyclic position (acylhydrazine moieties). With this second generation of compounds, we successfully decreased the IC50 until 7 µM. An in-depth analysis of their biological properties suggests that these promising compounds trigger a non-conventional cell death mechanism known as paraptosis. Moreover, the tested photophysical properties of these products show in some cases an interesting long wavelength emission and excitation, potentially leading to new biosensors or theragnostic agents. Finally, in vivo assays concerning the acute toxicity in mice of two of the most active compounds (with an alkyl chain of seven carbon atoms in the acylhydrazine moiety) demonstrated that even dosed at thousands fold the corresponding IC50 values (2500 and 3300 times more concentrated than the IC50 values for the two compounds studied), there was no sign of harmful effects on the tested subjects, results that support their use in further studies to discover new anticancer drugs.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Dual emissive ir(Iii) complexes for photodynamic therapy and bioimaging

  • Redrado M.
  • Benedi A.
  • Marzo I.
  • Gimeno M.C.
  • Fernández-Moreira V.
Photodynamic therapy (PDT) is a cancer treatment still bearing enormous prospects of improvement. Within the toolbox of PDT, developing photosensitizers (PSs) that can specifically reach tumor cells and promote the generation of high concentration of reactive oxygen species (ROS) is a constant research goal. Mitochondria is known as a highly appealing target for PSs, thus being able to assess the biodistribution of the PSs prior to its light activation would be crucial for therapeutic maximization. Bifunctional Ir(III) complexes of the type [Ir(CˆN)2 (NˆN-R)]+, where NˆC is either phenylpyridine (ppy) or benzoquinoline (bzq), NˆN is 2, 2'-dipyridylamine (dpa) and R either anthracene (1 and 3) or acridine (2 and 4), have been developed as novel trackable PSs agents. Activation of the tracking or therapeutic function could be achieved specifically by irradiating the complex with a different light wavelength (405 nm vs. 470 nm respectively). Only complex 4 ([Ir(bzq)2(dpa-acr)]+) clearly showed dual emissive pattern, acridine based emission between 407–450 nm vs. Ir(III) based emission between 521 and 547 nm. The sensitivity of A549 lung cancer cells to 4 evidenced the importance of involving the metal center within the activation process of the PS, reaching values of photosensitivity over 110 times higher than in dark conditions. Moreover, complex 4 promoted apoptotic cell death and possibly the paraptotic pathway, as well as higher ROS generation under irradiation than in dark conditions. Complexes 2–4 accumulated in the mitochondria but species 2 and 4 also localizes in other subcellular organelles.